ZNF806

Across TCGA pan-cancer cohorts, ZNF806 mass-spec protein is linked to patient survival in 3 of 34 cancer types, making it a survival-associated ZNF806 data layer compared with 15 for mass-spec protein and 2 for mutation status.

The strongest signal is observed in colon adenocarcinoma (COAD), where higher ZNF806 mass-spec protein is associated with better disease-free survival. In most high-consensus cancer types, elevated ZNF806 expression acts as an unfavorable survival marker, although some lineages such as COAD and PDAC show a favorable association.

COAD, PDAC, and GBM are the cancer types where ZNF806 mass-spec protein most reproducibly stratifies survival.

mass-spec protein survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
COAD	DFS	Median	II,III,IV	1.000	0.910	.041	18	view →
PDAC	OS	Median	III,IV	0.824	0.286	.006	18	view →
GBM	OS	Median	All	0.684	0.915	.016	2	view →

Pink = unfavorable, green = favorable. Showing the 3 strongest of 3 lineages.

ZNF806–COAD (DFS)

Open the COAD breakdown →